Pages that link to "Q34774333"

The following pages link to Controversies in lung transplantation: management of cytomegalovirus infections (Q34774333):

Displaying 16 items.

• CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients (Q26768473) (← links)
• Monoclonal antibody therapy and renal transplantation: focus on adverse effects (Q26826880) (← links)
• Critical care aspects of lung transplantation (Q33360317) (← links)
• Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients (Q33932079) (← links)
• Lung transplantation: opportunities for research and clinical advancement (Q36195432) (← links)
• Critical care perspective on immunotherapy in lung transplantation (Q36649380) (← links)
• Update on lung transplantation (Q37362628) (← links)
• A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients. (Q44566761) (← links)
• Recommendations for the use of extended criteria donors in lung transplantation. (Q45220571) (← links)
• Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients (Q46364896) (← links)
• Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients (Q46874022) (← links)
• Is gammaglobulin anti-CMV warranted in lung transplantation? (Q46874025) (← links)
• Clinical usefulness of bronchoalveolar lavage in heart transplant recipients with suspected lower respiratory tract infection (Q47983136) (← links)
• Blood cyclosporine C0 and C2 concentrations and cytomegalovirus infections following lung transplantation (Q57218408) (← links)
• Infections in Heart and Lung Transplant Recipients (Q91902557) (← links)
• Burden of cytomegalovirus reactivation post kidney transplant with antithymocyte globulin use in Thailand: A retrospective cohort study (Q93354461) (← links)